Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Arthritis Research & Therapy
|
July 27, 2017
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity
Cristiano Alessandri, Francesco Ciccia, Roberta Priori, et al.
Arthritis Research & Therapy
|
April 3, 2016
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey
Roberta Ramonda, Antonio Marchesoni, Antonio Carletto, et al.
Rheumatology (Oxford, England)
|
September 19, 2020
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome
Maria Juarez, Nieves Diaz, Geoffrey I Johnston, et al.
Autoimmunity Reviews
|
July 17, 2012
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry
Fabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, et al.
The Journal of Rheumatology
|
July 6, 2007
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study
Luana Mancarella, Francesca Bobbio-Pallavicini, Fulvia Ceccarelli, et al.
Clinical Rheumatology
|
May 22, 2016
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients
Paolo Sfriso, Roberta Priori, Guido Valesini, et al.
Joint Bone Spine
|
August 2, 2014
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register
Marco Sebastiani, Maria Grazia Anelli, Fabiola Atzeni, et al.
Autoimmunity Reviews
|
December 16, 2020
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus
Roberto Giacomelli, Antonella Afeltra, Elena Bartoloni, et al.
Autoimmunity Reviews
|
July 15, 2017
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management
Roberto Giacomelli, Antonella Afeltra, Alessia Alunno, et al.
Autoimmunity Reviews
|
July 28, 2024
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Piero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Arthritis Research & Therapy
|
July 27, 2017
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity
Cristiano Alessandri, Francesco Ciccia, Roberta Priori, et al.
Arthritis Research & Therapy
|
April 3, 2016
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey
Roberta Ramonda, Antonio Marchesoni, Antonio Carletto, et al.
Rheumatology (Oxford, England)
|
September 19, 2020
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome
Maria Juarez, Nieves Diaz, Geoffrey I Johnston, et al.
Autoimmunity Reviews
|
July 17, 2012
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry
Fabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, et al.
The Journal of Rheumatology
|
July 6, 2007
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study
Luana Mancarella, Francesca Bobbio-Pallavicini, Fulvia Ceccarelli, et al.
Clinical Rheumatology
|
May 22, 2016
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients
Paolo Sfriso, Roberta Priori, Guido Valesini, et al.
Joint Bone Spine
|
August 2, 2014
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register
Marco Sebastiani, Maria Grazia Anelli, Fabiola Atzeni, et al.
Autoimmunity Reviews
|
December 16, 2020
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus
Roberto Giacomelli, Antonella Afeltra, Elena Bartoloni, et al.
Autoimmunity Reviews
|
July 15, 2017
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management
Roberto Giacomelli, Antonella Afeltra, Alessia Alunno, et al.
Autoimmunity Reviews
|
July 28, 2024
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Piero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Page
of 9